1275 related articles for article (PubMed ID: 17084330)
41. [Effect of total mesorectal excision and preoperative chemoradiotherapy on local recurrence in rectal cancer].
Wu AW; Gu J; Wang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):207-9. PubMed ID: 16721678
[TBL] [Abstract][Full Text] [Related]
42. Recurrence after transanal excision of T1 rectal cancer: should we be concerned?
Madbouly KM; Remzi FH; Erkek BA; Senagore AJ; Baeslach CM; Khandwala F; Fazio VW; Lavery IC
Dis Colon Rectum; 2005 Apr; 48(4):711-9; discussion 719-21. PubMed ID: 15768186
[TBL] [Abstract][Full Text] [Related]
43. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer.
Iizasa T; Suzuki M; Yoshida S; Motohashi S; Yasufuku K; Iyoda A; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T
Ann Thorac Surg; 2006 Jul; 82(1):254-60. PubMed ID: 16798225
[TBL] [Abstract][Full Text] [Related]
44. Transanal local wide excision for rectal adenocarcinoma.
Chen CC; Leu SY; Liu MC; Jian JJ; Chen CM
Hepatogastroenterology; 2005; 52(62):460-3. PubMed ID: 15816457
[TBL] [Abstract][Full Text] [Related]
45. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
[TBL] [Abstract][Full Text] [Related]
46. Depth of mesorectal invasion has prognostic significance in T3N0 low rectal cancer.
Tokoro T; Okuno K; Hida J; Ishimaru E; Ueda K; Yoshifuji T
Hepatogastroenterology; 2009; 56(89):124-7. PubMed ID: 19453042
[TBL] [Abstract][Full Text] [Related]
47. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
[TBL] [Abstract][Full Text] [Related]
48. The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam.
Visser O; Bakx R; Zoetmulder FA; Levering CC; Meijer S; Slors JF; van Lanschot JJ
J Surg Oncol; 2007 May; 95(6):447-54. PubMed ID: 17048237
[TBL] [Abstract][Full Text] [Related]
49. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer.
Vecchio FM; Valentini V; Minsky BD; Padula GD; Venkatraman ES; Balducci M; Miccichè F; Ricci R; Morganti AG; Gambacorta MA; Maurizi F; Coco C
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):752-60. PubMed ID: 15936556
[TBL] [Abstract][Full Text] [Related]
50. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
[TBL] [Abstract][Full Text] [Related]
51. Total mesorectal excision (TME) with laparoscopic approach: 226 consecutive cases.
Staudacher C; Di Palo S; Tamburini A; Vignali A; Orsenigo E
Surg Oncol; 2007 Dec; 16 Suppl 1():S113-6. PubMed ID: 18054221
[TBL] [Abstract][Full Text] [Related]
52. Rectal cancer surgery in the elderly: a multivariate analysis of outcome risk factors.
Bufalari A; Giustozzi G; Burattini MF; Servili S; Bussotti C; Lucaroni E; Ricci E; Sciannameo F
J Surg Oncol; 2006 Mar; 93(3):173-80. PubMed ID: 16482596
[TBL] [Abstract][Full Text] [Related]
53. Oncologic outcomes of robotic-assisted total mesorectal excision for the treatment of rectal cancer.
Baek JH; McKenzie S; Garcia-Aguilar J; Pigazzi A
Ann Surg; 2010 May; 251(5):882-6. PubMed ID: 20395863
[TBL] [Abstract][Full Text] [Related]
54. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
[TBL] [Abstract][Full Text] [Related]
55. [Multivariate prognostic analysis of patients with low and middle rectal cancer after curative resection].
Li CS; Wan DS; Pan ZZ; Zhou ZW; Chen G; Wu XJ; Li LR; Lu ZH; Ding PR; Li Y
Ai Zheng; 2006 May; 25(5):587-90. PubMed ID: 16687079
[TBL] [Abstract][Full Text] [Related]
56. Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival.
Rullier A; Laurent C; Capdepont M; Vendrely V; Belleannée G; Bioulac-Sage P; Rullier E
Am J Surg Pathol; 2008 Jan; 32(1):45-50. PubMed ID: 18162769
[TBL] [Abstract][Full Text] [Related]
57. [Long-term result of low anterior resection with stapling devices for rectal cancer].
Pan ZZ; Wan DS; Ding PR; Li LR; Chen G; Wu XJ; Zhou ZW; Lu ZH; Wan XB; Li CM
Ai Zheng; 2004 Nov; 23(11 Suppl):1508-11. PubMed ID: 15566668
[TBL] [Abstract][Full Text] [Related]
58. Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy.
Giralt J; Navalpotro B; Hermosilla E; de Torres I; Espin E; Reyes V; Cerezo L; de las Heras M; Ramon y Cajal S; Armengol M; Benavente S
Oncology; 2006; 71(5-6):312-9. PubMed ID: 17687192
[TBL] [Abstract][Full Text] [Related]
59. Results of long-term follow-up for transanal excision for rectal cancer.
Gonzalez QH; Heslin MJ; Shore G; Vickers SM; Urist MM; Bland KI
Am Surg; 2003 Aug; 69(8):675-8; discussion 678. PubMed ID: 12953825
[TBL] [Abstract][Full Text] [Related]
60. Outcomes of resection of stage IV rectal cancer with mesorectal excision.
Law WL; Chu KW
J Surg Oncol; 2006 Jun; 93(7):523-8. PubMed ID: 16705728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
